Alexei Miagkov, Ph.D.,
Senior Scientist, Immunology, ATCC
Alexei Miagkov leads the Tumor Immunology group at ATCC Cell Systems. Prior to joining ATCC, Dr. Miagkov served as the Scientific Program Manager at PerkinElmer, where he was responsible for the design, validation, and implementation of assays intended for preclinical studies in oncology and inflammatory diseases. He also held progressing scientific roles at Caliper Life Sciences and NovaScreen Biosciences. Dr. Miagkov completed a post-doctoral fellowship in neuro-immunology at Johns Hopkins University, and earned his Ph.D. in cell biology and M.S. in cellular immunology and microbiology from Moscow State University.